Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JMKX000189 for induction and maintenance treatment of moderate to severe ulcerative colitis
ChiCTR2400089087Phase 3Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of JMKX000189 in autoimmune colitis (5 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Percentage of subjects who achieved clinical remission by week 12 and Percentage of subjects who achieved clinical remission in week 52. Started Sep 2024; status: recruiting.
02
Drugs
JMKX000189
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on ChiCTR2400089087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089087.